Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 4/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | LPL | P06858 | 1/20 | 0.47 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | NT5E | P21589 | 1/20 | 0.46 |
| ▸ | HTR2A | P28223 | 1/20 | 0.46 |
| ▸ | HTR2C | P28335 | 1/20 | 0.46 |
| ▸ | PLK1 | P53350 | 1/20 | 0.46 |
| ▸ | CNR2 | P34972 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28032891 | 0.98 | CA2 (0.62) | CA2SMN1; SMN2FFAR4LMNAALDH1A1 | |
| Hydrochloric Acid SCHEMBL27609749 | 0.98 | CA2 (0.62) | CA2SMN1; SMN2FFAR4LMNAALDH1A1 | |
| Ammonia Solution, Strong SCHEMBL28250586 | 0.98 | CA2 (0.62) | CA2SMN1; SMN2FFAR4LMNAALDH1A1 | |
| SCHEMBL8430251 | 0.98 | CA2 (0.62) | CA2SMN1; SMN2FFAR4LMNAALDH1A1 | |
| SCHEMBL269162 | 0.88 | CA2 (0.67) | CA2SMN1; SMN2FFAR4LMNAALDH1A1 | |
| Trolamine SCHEMBL4532988 | 0.86 | CA2 (0.50) | CA2SMN1; SMN2FFAR4LMNAALDH1A1 | |
| SCHEMBL11583429 | 0.86 | LMNA (0.56) | CA2SMN1; SMN2LMNAALDH1A1TSHR | |
| SCHEMBL28033371 | 0.86 | CA2 (0.65) | CA2SMN1; SMN2FFAR4LMNAALDH1A1 | |
| SCHEMBL1300965 | 0.86 | CA2 (0.68) | CA2SMN1; SMN2LMNAALDH1A1HTT | |
| Hydrochloric Acid SCHEMBL27729209 | 0.86 | CA2 (0.65) | CA2SMN1; SMN2FFAR4LMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 271 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260034124-A1 | NOVEL SALTS AND CRYSTALS | INTRA CELLULAR THERAPIES INC (US) | 2026-02-05 | — | — | US | claimed |
| EP-4561569-A2 | NOVEL SALTS AND CRYSTALS | Intra-Cellular Therapies, Inc. (US) | 2025-06-04 | — | — | EP | claimed |
| US-11945909-B2 | Process for preparing polycarbonates using a catalyst system having a quarternary nitrogen compond and a quarternary phosphorous compound | EPC Engineering & Technologies GmbH (DE) | 2024-04-02 | — | — | US | claimed |
| WO-2024030835-A2 | NOVEL SALTS AND CRYSTALS | INTRA-CELLULAR THERAPIES, INC. (US) | 2024-02-08 | — | — | WO | claimed |
| EP-3526274-B1 | CATALYST SYSTEM | EPC ENGINEERING & TECH GMBH (DE) | 2022-08-03 | — | — | EP | claimed |
| CN-114686888-A | Chemical mechanical polishing solution and application thereof | 安集微电子科技（上海）股份有限公司 | 2022-07-01 | — | — | CN | claimed |
| US-8986728-B2 | Soluble implantable device comprising polyelectrolyte with hydrophobic counterions | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2015-03-24 | — | — | US | claimed |
| EP-0808337-A1 | EPOXY RESIN COMPOSITION CAPABLE OF CURE AT LOW TEMPERATURE | THE DOW CHEMICAL COMPANY (US) | 1997-11-26 | — | — | EP | claimed |
| WO-1996024628-A1 | EPOXY RESIN COMPOSITION CAPABLE OF CURE AT LOW TEMPERATURE | DOW DEUTSCHLAND INC. (DE) | 1996-08-15 | — | — | WO | claimed |
| US-5364925-A | Epoxy resin advanced with a dihydric phenol and further chain extended with an additional dihydric phenol for use in electrical laminates | THE DOW CHEMICAL COMPANY (US) | 1994-11-15 | — | — | US | claimed |
| EP-0507271-A2 | Epoxy resin compositions for use in electrical laminates | THE DOW CHEMICAL COMPANY (US) | 1992-10-07 | — | — | EP | claimed |
| EP-0497284-A2 | Epoxy resin compositions for use in electrical laminates | THE DOW CHEMICAL COMPANY (US) | 1992-08-05 | — | — | EP | claimed |
| US-4349625-A | ALBUMIN USING ACYL-COENZYME A SYNTHETASE | MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) | 1982-09-14 | — | — | US | claimed |
| US-20260034124-A1 | NOVEL SALTS AND CRYSTALS | INTRA CELLULAR THERAPIES INC (US) | 2026-02-05 | — | — | US | disclosed |
| US-20250352469-A1 | NOVEL COMPOSITIONS, DEVICES, AND METHODS | INTRA CELLULAR THERAPIES INC (US) | 2025-11-20 | — | — | US | disclosed |
| EP-4561569-A2 | NOVEL SALTS AND CRYSTALS | Intra-Cellular Therapies, Inc. (US) | 2025-06-04 | — | — | EP | disclosed |
| US-4110116-A | Fogged direct positive silver halide emulsion containing a cyanine dye having at least one benzoxazole or benzothiazole nucleus substituted with halogen atoms | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1978-08-29 | — | — | US | disclosed |
| US-4038225-A | ALKYD RESIN, MELAMINE RESIN, ORGANOSULFONIC ACID, SOLVENT | KANSAI PAINT COMPANY, LTD. (JA) | 1977-07-26 | — | — | US | disclosed |
| US-3972873-A | Certain pyrido[3,2-e]1,4-diazepinones and derivatives | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DT) | 1976-08-03 | — | — | US | disclosed |
| US-3955984-A | STYRYL DYES | FUJI PHOTO FILM CO., LTD. (JA) | 1976-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260034124-A1 | NOVEL SALTS AND CRYSTALS | SLC6A4, SLC6A3, HTR2A | CA2 1503/4885SMN1; SMN2 2213/4885FFAR4 1115/4885 |
| US-20250352469-A1 | NOVEL COMPOSITIONS, DEVICES, AND METHODS | LIPA, DHCR7, HSD17B7 | CA2 4076/4885SMN1; SMN2 1299/4885FFAR4 434/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.